Moneycontrol PRO
Outskill Genai
HomeNewsBusinessStocksBuy Dabur India, Vedanta, Torrent Pharma: Sudarshan Sukhani

Buy Dabur India, Vedanta, Torrent Pharma: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com suggests buying Dabur India, Vedanta and Torrent Pharma.

January 15, 2018 / 12:00 IST

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "For today Dabur India is a buying opportunity. This stock has been outperforming and is breaking out from a very narrow range which lasted for a few days. Vedanta is a buy. Metals are doing well and Vedanta is outperforming. Torrent Pharma which has been giving a spectacular gains for the last few weeks continues to do so. So three ideas to buy but don’t go short."

"One can hold Titan Company. The current price is immaterial. The stock is outperforming the broad market. In the next few years you will be surprised that the prices you see in this stock hold on, don’t do anything else."

"NBFCs and private sector banks are good opportunities for the week. But beyond that it is difficult to say, for a short-term trader different sectors may come on the floor later but at least for today and tomorrow the focus should be even more on private sector banks, more than NBFCs look at private sector banks."

"The idea is to hold on Eicher Motors but for the next one year I don’t see Eicher Motors going through a big rally. It has already done that. This could easily be a period of consolidation. Expect consolidation in a next one year and gains in the next three to five years," he said.

CNBC-TV18
first published: Jan 15, 2018 11:52 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347